LEXARIA BIOSCIENCE CORP. Marketable Securities (Current)
LEXARIA BIOSCIENCE CORP. (LEXX) had Marketable Securities (Current) of $0 as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-07-13
- 2026-05-31: Marketable Securities, Current $0.00.
- 2026-02-28: Marketable Securities, Current $0.00.
- 2025-11-30: Marketable Securities, Current $0.00.
- 2025-08-31: Marketable Securities, Current $22.09K.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-05-31 | $0.00 10-Q · filed 2026-07-13 |
| 2026-02-28 | $0.00 10-Q · filed 2026-04-13 |
| 2025-11-30 | $0.00 10-Q · filed 2026-01-13 |
| 2025-08-31 | $22.09K 10-Q · filed 2026-07-13 |
| 2025-05-31 | $33.54K 10-Q · filed 2025-07-14 |
| 2025-02-28 | $73.92K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $39.88K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $55.81K 10-K · filed 2025-11-28 |
| 2024-05-31 | $46.31K 10-Q · filed 2024-07-12 |
| 2024-02-29 | $87.70K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $72.43K 10-Q · filed 2024-01-12 |
| 2023-08-31 | $125.64K 10-K · filed 2024-11-26 |
| 2023-05-31 | $269.56K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $267.70K 10-Q · filed 2023-04-14 |
| 2022-11-30 | $269.71K 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $347.33K 10-K · filed 2023-11-20 |
| 2022-05-31 | $288.03K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $552.32K 10-Q · filed 2022-04-11 |
| 2021-11-30 | $493.42K 10-Q · filed 2022-01-14 |
| 2021-08-31 | $833.84K 10-K · filed 2022-11-28 |
| 2021-05-31 | $400.74K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $470.63K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $43.73K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $19.32K 10-K · filed 2021-11-29 |
| 2020-05-31 | $18.28K 10-Q · filed 2020-06-29 |
| 2020-02-29 | $23.62K 10-Q · filed 2020-04-03 |
| 2019-11-30 | $22.64K 10-Q · filed 2020-01-09 |
| 2019-08-31 | $64.21K 10-K · filed 2020-10-15 |
| 2019-05-31 | $74.84K 10-Q · filed 2019-07-08 |
| 2019-02-28 | $71.13K 10-Q · filed 2019-04-15 |
| 2018-11-30 | $71.02K 10-Q · filed 2019-01-11 |
| 2018-08-31 | $10.15K 10-K · filed 2019-11-14 |
| 2018-05-31 | $17.62K 10-Q · filed 2018-07-13 |
| 2017-08-31 | $0.00 10-Q · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |